{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:32:30Z","timestamp":1793917950481,"version":"4.8.0"},"reference-count":36,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T00:00:00Z","timestamp":1619222400000},"content-version":"unspecified","delay-in-days":99,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals SA","doi-asserted-by":"crossref","award":["HO-18-19371"],"award-info":[{"award-number":["HO-18-19371"]}],"id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2021,6,3]]},"DOI":"10.1080\/21645515.2020.1849518","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T14:31:09Z","timestamp":1610721069000},"page":"1858-1866","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":56,"title":["Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0716-3174","authenticated-orcid":false,"given":"Muhamed-Kheir","family":"Taha","sequence":"first","affiliation":[{"name":"Invasive Bacterial Infections Unit, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5271-1945","authenticated-orcid":false,"given":"Catherine","family":"Weil-Olivier","sequence":"additional","affiliation":[{"name":"Service de P\u00e9diatrie, Universit\u00e9 de Paris VII Diderot, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6838-2680","authenticated-orcid":false,"given":"St\u00e9phane","family":"Bou\u00e9e","sequence":"additional","affiliation":[{"name":"RWE Department, CEMKA-EVAL, Bourg-la-Reine, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7333-0567","authenticated-orcid":false,"given":"Corinne","family":"Emery","sequence":"additional","affiliation":[{"name":"RWE Department, CEMKA-EVAL, Bourg-la-Reine, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5116-0723","authenticated-orcid":false,"given":"Ga\u00eblle","family":"Nachbaur","sequence":"additional","affiliation":[{"name":"Vaccine Medical Department, GSK, Rueil-Malmaison, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3126-0572","authenticated-orcid":false,"given":"C\u00e9line","family":"Pribil","sequence":"additional","affiliation":[{"name":"Vaccine Medical Department, GSK, Rueil-Malmaison, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6397-7922","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Loncle-Provot","sequence":"additional","affiliation":[{"name":"Vaccine Medical Department, GSK, Rueil-Malmaison, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41479-019-0062-0"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2018.00321"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0195941700062482"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.063"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1586\/eri.13.42"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70048-7"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-018-0213-2"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.03.007"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1904.111799"},{"key":"e_1_3_6_11_1","volume-title":"Annual epidemiological report for 2017","author":"European Centre for Disease Prevention and Control","year":"2019","unstructured":"European Centre for Disease Prevention and Control. Invasive meningococcal disease. In: ECDC, editor. Annual epidemiological report for 2017. Stockholm: ECDC; 2019."},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2019-318047"},{"key":"e_1_3_6_13_1","first-page":"1","article-title":"Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countries","author":"Taha MK","year":"2020","unstructured":"Taha MK, Gaudelus J, Deghmane AE, Caron F. Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countries. Hum Vaccin Immunother. 2020;1\u20136.","journal-title":"Hum Vaccin Immunother"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31815c1b3a"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38725.728472.BE"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2307.160129"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4233"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0674-5"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/ecc.13117"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214649"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221211"},{"key":"e_1_3_6_22_1","first-page":"333","article-title":"Statement of the German Standing Committee on Vaccination at the RKIRecommendations of the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute \u2013 2017\/201","volume":"34","author":"STIKO","year":"2017","unstructured":"STIKO. Statement of the German Standing Committee on Vaccination at the RKIRecommendations of the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute \u2013 2017\/201. Epid Bull. 2017;34:333\u201376.","journal-title":"Epid Bull"},{"key":"e_1_3_6_24_1","volume-title":"Complete immunisation schedule","author":"National Health Service","year":"2018","unstructured":"National Health Service. Complete immunisation schedule. London, UK: NHS; 2018."},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyh169"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00155-09"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1086\/379719"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-9-33"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2017.02.011"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.1.144-149.2005"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1804776"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1051276"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-160-1-201401070-00731"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0538-6"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1086\/313617"},{"key":"e_1_3_6_38_1","first-page":"1","article-title":"Social and environmental influences affecting the risk of development of meningococcal disease: considerations for prehospital care","volume":"4","author":"Burgess S","year":"2006","unstructured":"Burgess S. Social and environmental influences affecting the risk of development of meningococcal disease: considerations for prehospital care. J Emerg Prim Health Care. 2006;4:1\u201310.","journal-title":"J Emerg Prim Health Care"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2003.036004"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-4-30"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2020.1849518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T09:50:00Z","timestamp":1709286600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2020.1849518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6,3]]}},"alternative-id":["10.1080\/21645515.2020.1849518"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2020.1849518","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-08-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}